David Pyott
Vermögen: 9 Mio $ am 31.05.2026
Vermögen: 9 Mio $ am 31.05.2026
David E. I. Pyott ist ein britischer Geschäftsmann, der bereits an der Spitze von 7 verschiedenen Unternehmen stand. Derzeit bekleidet er die Position des Vorsitzenden von Bioniz Therapeutics, Inc, des Chief Executive Officer & Director bei Serica Technologies, Inc. und des Präsidenten von Vicept Therapeutics, Inc. Dr. Pyott ist außerdem Präsident der International Council of Ophthalmology Foundation und sitzt im Vorstand von 13 weiteren Unternehmen. David E. I. Pyott war zuvor Head-Nutrition Division bei der Novartis AG und President & Chief Executive Officer für Sandoz Nutrition Corp. (eine Tochtergesellschaft der Novartis AG), Chairman & Chief Executive Officer bei Allergan, Inc. und Chairman für das California Healthcare Institute. Er erwarb einen Abschluss an der University of Edinburgh und einen MBA an der London Business School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 29’482 ( 0.02% ) | 9 Mio $ | 31.05.2026 | |
| 25.06.2026 | 9’374 ( 0.02% ) | 556 816 $ | 31.05.2026 | |
| 15.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 18.12.2015 |
| TARSUS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 18.02.2026 |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Direktor/Vorstandsmitglied | 01.03.2013 |
Ophthalmology Foundation
Ophthalmology Foundation Miscellaneous Commercial ServicesCommercial Services The Ophthalmology Foundation is a U.S.-based 501(c)(3) nonprofit organization dedicated to advancing ophthalmic education and improving eye care worldwide, with a focus on underserved and low-resource regions. The private company is based in San Francisco, CA. The organization empowers vision care through accessible, high-quality education, faculty development, and professional growth for ophthalmologists and eye care professionals. Key initiatives include internationally recognized, low-cost online examinations aligned with American Academy of Ophthalmology standards, offered biannually at local host centers worldwide to reduce travel barriers. The foundation plans to expand exam offerings with new subspecialty tests in retina and glaucoma launching in 2027. Top-performing candidates outside the U.S. may receive travel grants to attend international conferences or pursue specialized training. Faculty development is a core focus, with programs designed to enhance teaching skills through mentorships, symposia, workshops, webinars, simulation-based education, and online courses offering continuing professional development credits. The foundation’s educator’s certificate program certifies teaching competence, enabling educators to participate as faculty in educational interventions. Its faculty development committee oversees program quality and volunteer recruitment. Additional offerings include subspecialty fellowships awarding 80-100 grants annually across 20 areas, accreditation of residency programs to meet international standards, and collaborative partnerships with leading institutions and organizations worldwide. The foundation emphasizes equity, inclusion, and ethical standards, tailoring programs to regional needs through an international advisory committee. | Präsident | 01.11.2020 |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | 01.01.2019 |
London Business School
London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Vorsitzender | - |
Bioniz Therapeutics, Inc.
Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Vorsitzender | 01.08.2016 |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops dermatologic therapeutic products | Präsident | - |
Paul Merage School of Business
Paul Merage School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 28 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Avery Dennison Corp.
Avery Dennison Corp. Pulp & PaperProcess Industries Designs and develops labeling and functional materials, radio frequency identification inlays, tags & software applications | Process Industries |
Koninklijke Philips NV
Koninklijke Philips NV Medical/Nursing ServicesHealth Services Provides image, cardiovascular, diagnostic imaging, ambulatory, sleep therapy and personal healthcare services | Health Services |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Edwards Lifesciences Corp.
Edwards Lifesciences Corp. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets products to treat late-stage cardiovascular disease | Health Technology |
Pacific Mutual Holding Co.
Pacific Mutual Holding Co. Insurance Brokers/ServicesFinance Provides insurance, financial and other investment services | Finance |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Serica Technologies, Inc.
Serica Technologies, Inc. Pharmaceuticals: MajorHealth Technology Distributes silk based biomaterial products for tissue rejuvenation | Health Technology |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops dermatologic therapeutic products | Health Technology |
Bioniz Therapeutics, Inc.
Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Commercial Services |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Pacific LifeCorp
Pacific LifeCorp Life/Health InsuranceFinance Provides life insurance, retirement and employee benefits services | Finance |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Chapman University
Chapman University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Edinburgh
The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Healthcare Institute
California Healthcare Institute BiotechnologyHealth Technology Provides biomedical community services | Health Technology |
Pan-American Ophthalmological Foundation | |
International Council of Ophthalmology Foundation | |
Cosmetic Surgery Foundation, Inc. | |
Sandoz Nutrition Corp. | |
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins and antibodies | Health Technology |
Paul Merage School of Business
Paul Merage School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis | Health Technology |
Ophthalmology Foundation
Ophthalmology Foundation Miscellaneous Commercial ServicesCommercial Services The Ophthalmology Foundation is a U.S.-based 501(c)(3) nonprofit organization dedicated to advancing ophthalmic education and improving eye care worldwide, with a focus on underserved and low-resource regions. The private company is based in San Francisco, CA. The organization empowers vision care through accessible, high-quality education, faculty development, and professional growth for ophthalmologists and eye care professionals. Key initiatives include internationally recognized, low-cost online examinations aligned with American Academy of Ophthalmology standards, offered biannually at local host centers worldwide to reduce travel barriers. The foundation plans to expand exam offerings with new subspecialty tests in retina and glaucoma launching in 2027. Top-performing candidates outside the U.S. may receive travel grants to attend international conferences or pursue specialized training. Faculty development is a core focus, with programs designed to enhance teaching skills through mentorships, symposia, workshops, webinars, simulation-based education, and online courses offering continuing professional development credits. The foundation’s educator’s certificate program certifies teaching competence, enabling educators to participate as faculty in educational interventions. Its faculty development committee oversees program quality and volunteer recruitment. Additional offerings include subspecialty fellowships awarding 80-100 grants annually across 20 areas, accreditation of residency programs to meet international standards, and collaborative partnerships with leading institutions and organizations worldwide. The foundation emphasizes equity, inclusion, and ethical standards, tailoring programs to regional needs through an international advisory committee. | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen